Viral load driven treatment interruption    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
265Lipodystrophy1

265. Lipodystrophy    [ 109 clinical trials,   164 drugs,   (DrugBank: 59 drugs),   26 drug target genes,   94 drug target pathways]
Searched query = "Lipodystrophy", "Berardinelli-Seip syndrome", "Lawrence syndrome", "Barraquer-Simons syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 109 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00646984
(ClinicalTrials.gov)
January 200226/3/2008Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With LipodystrophyComparison of Strategies of Interruption/Reinitiation of Antiretroviral Therapy in Response to Immunologic/Virologic Changes in HIV-Infected Patients With Lipodystrophy.HIV-Associated Lipodystrophy SyndromeDrug: Standard continuous antiretroviral therapy;Drug: CD-4 guided therapy interruption;Drug: Viral load driven treatment interruptionHospital Clinic of BarcelonaNULLCompleted18 YearsN/ABoth147Phase 4Spain